Kapvay, ADHD treatment for children and adolescents.
Shade-Buttons
Kapvay Home

  Indication  |  Important Safety Information | Contact Us

Yellow-line

Kapvay™ is an FDA-approved non-stimulant Attention Deficit Hyper-activity Disorder treatment for children and adolescents (age 6-17), that can be used with or without stimulant therapy.

Welcome to Kapvay™

Kapvay™ (clonidine hydrochloride) extended-release tablets are indicated for the treatment of attention deficit/hyperactivity disorder (ADHD). When combined with a stimulant medication, Kapvay™ may help ADHD patients as part of a comprehensive ADHD treatment plan.

If your child is not getting the symptom relief the doctor had hoped for, adding Kapvay™ may help.

Learn more >>

Understanding ADHD

ADHD is the most commonly diagnosed childhood behavioral disorder. As of 2007, approximately 5.4 million children and adolescents have been diagnosed with ADHD.

Children with ADHD experience periods of not paying attention, overactivity, being impulsive, or a combination of these symptoms. In order for these symptoms to be diagnosed as ADHD, they must be out of the normal range for a child’s age and development.

Learn more >>

Results

In clinical trials, most children and adolescents showed improvement in symptoms at Week 5.

After your child starts taking Kapvay™, it may take a while before you start noticing a difference in behavior. In order to meet your child’s individual needs, your child’s doctor must adjust the dose of Kapvay™ during treatment.

Learn more >>

Important Safety Information for Patients

  • Do not take Kapvay™ if you are allergic to clonidine
  • Use Kapvay™ with caution if you have high or low blood pressure, kidney problems, or heart problems, including heart attacks or strokes. You should avoid becoming dehydrated or overheated when taking Kapvay™
  • Kapvay™ can make you sleepy or dizzy. Do not drink alcohol or take other medicines that make you sleepy or dizzy while taking Kapvay™ until you talk with your doctor. Kapvay™ taken with alcohol or medicines that cause sleepiness or dizziness may make your sleepiness or dizziness worse
  • Do not drive, operate heavy machinery, or participate in any dangerous activities until you know how Kapvay™ will affect you
  • Do not stop taking Kapvay™ without talking to your doctor. Suddenly stopping Kapvay™ may cause withdrawal symptoms, including increased blood pressure, headache, increased heart rate, lightheadedness, tightness in your chest, and nervousness
  • Tell your doctor if you had a skin reaction (such as a rash) after taking clonidine in a transdermal form (skin patch). Talk to your doctor about any other medical conditions you have and all the medicines, including vitamins and supplements, that you take
  • The most common side effects of Kapvay™ include sleepiness, tiredness, and upper respiratory tract infection (Symptoms may include cough, runny nose, and sneezing) irritability, sore throat, trouble sleeping (insomnia), nightmares, change in mood, constipation, stuffy nose, increased body temperature, dry mouth, and ear pain

Please see Important Patient Information within the Full Prescribing Information.

Indication

KAPVAY is a prescription medicine used for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) for children and adolescents aged 6-17. Your doctor may prescribe KAPVAY alone or in combination with ADHD stimulant medications.

  • KAPVAY should be used as part of a total treatment program for ADHD that may include counseling or other therapies.
Yellow-line

References: 1. Attention-deficit/hyperactivity disorder. Data and statistics. http://www.cdc.gov/ncbddd/adhd/data.html  Accessed March 16, 2011. 2. PubMed Health. Attention deficit hyperactivity disorder (ADHD). http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002518/ . Accessed 2/25/11.

Kapvay™ is a trademark of Shionogi Inc.

Shionogi Inc
© 2011 Shionogi Inc. Florham Park, NJ. All rights reserved.  KAP11-COT-001-00
www.Kapvay.com